Regeneron Pharmaceuticals

eyeball retinal diseases

Biotech

Unity's stock tumbles after eye treatment fails to match Eylea

Unity’s eye treatment failed to match Eylea at 20 weeks—the only time stamp in which the candidate was inferior to Regeneron’s blockbuster.

Gabrielle Masson Mar 24, 2025 11:11am

childrens art

Regeneron gene therapy restores hearing in 10 of 11 children

Feb 24, 2025 3:00pm

A graphic representation of a DNA sequence

JPM25: Regeneron, Illumina back Truveta to sequence 10M genomes

Jan 13, 2025 10:12am

graphic of a larger shark chomping up a smaller one

Regeneron snaps up eye biotech, snaring science but not staff

Jan 2, 2025 3:58pm

Graphic of a drop of blood made up of small data points and nodes

Regeneron anticoagulant bests enoxaparin, matches Eliquis

Dec 19, 2024 8:50am

gas burners cooking

ESMO: Regeneron's Opdualag rival shows 57% response rate

Sep 14, 2024 3:00am